-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cmbgvmr0i3Ywp33mfTi0E1g6KsKkt33vcg5zIk7wZ21KCQXWzLitfKalXtqvMdxo FQxhRPp5OCYKtn1cuarBpw== 0001209191-08-042854.txt : 20080717 0001209191-08-042854.hdr.sgml : 20080717 20080717172119 ACCESSION NUMBER: 0001209191-08-042854 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080131 FILED AS OF DATE: 20080717 DATE AS OF CHANGE: 20080717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 21000 BUSINESS PHONE: 972-4-988-9488 MAIL ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 21000 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Akirov Alfred CENTRAL INDEX KEY: 0001434514 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33357 FILM NUMBER: 08957776 BUSINESS ADDRESS: BUSINESS PHONE: 972-3-714-7770 MAIL ADDRESS: STREET 1: ALROV TOWER STREET 2: 46 ROTHSCHILD BLVD CITY: TEL AVIV STATE: L3 ZIP: 66883 3 1 c73960_3.xml MAIN DOCUMENT DESCRIPTION X0203 3 2008-01-31 0 0001006281 Protalix BioTherapeutics, Inc. PLX 0001434514 Akirov Alfred C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455 CARMIEL L3 20100 ISRAEL 1 0 0 0 Common Stock 6186046 I By Corporation All shares of common stock are held by Techno-Rov Holdings (1993) Ltd. Mr. Akirov is the Chairman of the Board and the Chief Executive Officer of the Alrov Group, which holds 80% of the capital stock of Techno-Rov Holdings. The Alrov Group is an Israeli publicly-traded company that is listed on the Tel Aviv Stock Exchange. Mr. Akirov disclaims beneficial ownership of the securities of the Issuer held, and previously reported, by Techno-Rov Holdings, except to the extent of his proportional pecuniary interest therein. /s/ Yossi Maimon, POA 2008-07-17 EX-24 2 c73960_24.htm POWER OF ATTORNEY Exhibit 24
Exhibit 24
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints David Aviezer, Ph.D., MBA and Yossi Maimon the undersigned’s true and lawful attorney-in-fact to: (i) execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended and the rules thereunder in connection with the undersigned’s holdings of and transactions in securities issued by Protalix BioTherapeutics, Inc., a Florida corporation (the “Company”); (ii) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any required stock exchange or similar authority, including the American Stock Exchange and (iii) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 13, 2008.
     
 
  /s/ Alfred Akirov
 
   
 
  Alfred Akirov

 

-----END PRIVACY-ENHANCED MESSAGE-----